Adderall XR 25 mghttp://www.unboundmedicine.com/medline/ebm/research/Adderall_XR_25_mgUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Methylphenidate and Amphetamine Do Not Induce Cytogenetic Damage in Lymphocytes of Children With ADHD.http://www.unboundmedicine.com/medline/ebm/record/18978633/full_citation/Methylphenidate_and_Amphetamine_Do_Not_Induce_Cytogenetic_Damage_in_Lymphocytes_of_Children_With_ADHD_Witt KL, Shelby MD, Itchon-Ramos N, et al. 
Methylphenidate and Amphetamine Do Not Induce Cytogenetic Damage in Lymphocytes of Children With ADHD. [JOURNAL ARTICLE]
J Am Acad Child Adolesc Psychiatry 2008 Oct 29.
Abstract | Full CitationBioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.http://www.unboundmedicine.com/medline/ebm/record/17519073/full_citation/Bioavailability_of_triple_bead_mixed_amphetamine_salts_compared_with_a_dose_augmentation_strategy_of_mixed_amphetamine_salts_extended_release_plus_mixed_amphetamine_salts_immediate_release_Ermer JC, Shojaei A, Pennick M, et al. 
Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. [Journal Article]
Curr Med Res Opin 2007 May; 23(5):1067-75.
Abstract | Full Citation | Find Related Articles Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.http://www.unboundmedicine.com/medline/ebm/record/16750455/full_citation/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__adderall_XR__in_the_management_of_oppositional_defiant_disorder_with_or_without_comorbid_attention_deficit/hyperactivity_disorder_in_school_aged_children_and_adolescents:_A_4_week_multicenter_randomized_double_blind_parallel_group_placebo_controlled_forced_dose_escalation_study_Spencer TJ, Abikoff HB, Connor DF, et al. 
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. [Journal Article]
Clin Ther 2006 Mar; 28(3):402-18.
Abstract | Full CitationA post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.http://www.unboundmedicine.com/medline/ebm/record/16678649/full_citation/A_post_hoc_subgroup_analysis_of_an_18_day_randomized_controlled_trial_comparing_the_tolerability_and_efficacy_of_mixed_amphetamine_salts_extended_release_and_atomoxetine_in_school_age_girls_with_attention_deficit/hyperactivity_disorder_Biederman J, Wigal SB, Spencer TJ, et al. 
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2006 Feb; 28(2):280-93.
Abstract | Full Citation | Publisher Full Text | Find Related Articles